BSE filing, NSE: LEMONTREE. Summary written from the filing by ALFA Finder's alert engine.
Lemon Tree Hotels Ltd: key numbers
- Share price
- ₹109.27
- Market cap
- ₹8,657 Cr
- Revenue (annual)
- ₹1,444 Cr
- Net profit (annual)
- ₹227.1 Cr
- P/E (TTM)
- 36.9×Sector 43.8×
- Promoter holding
- 22.32%+0.00% QoQ
- FII holding
- 18.27%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lemon Tree Hotels Ltd
All →Lemon Tree Hotels Board Meeting Date
Lemon Tree Hotels announced a board meeting on November 5, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Lemon Tree Hotels Capacity Expansion
Lemon Tree Hotels signed a licence agreement for a 63-room Keys Lite hotel in Bhilwara. The subsidiary-managed property expands its Rajasthan footprint; no value disclosed.
- hotel rooms
- 63.0 rooms
Lemon Tree Hotels Other Announcement
Lemon Tree Hotels Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This report details the company's equity distribution across various shareholder categories.
Lemon Tree Hotels Legal & Regulatory
Lemon Tree Hotels reported that the First Appellate Authority has partially allowed its subsidiary Fleur Hotels' appeal against a GST demand order. No material financial impact.
Lemon Tree Hotels Partnership
Lemon Tree Hotels signed an MoU with Omaxe Limited to operate approximately 4,000 hotel keys across India. This represents the company's largest single operating arrangement to date.
- From
- Omaxe Limited
- hotel keys
- 4000.0 keys
Lemon Tree Hotels Capacity Expansion
Lemon Tree Hotels signed a franchise agreement for a new hotel in Bareilly, Uttar Pradesh. The property will feature 52 rooms, expanding the company's network.
- hotel capacity
- 52.0 rooms
Other regulatory approval announcements
All →Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.